NCT02845284

Brief Summary

This randomized clinical trial is an adolescent focused implementation science study directed at improved social support and prevention of both HIV/STI's and subsequent unplanned pregnancies. The study population is pregnant adolescents who are attending antenatal care in Kampala, Uganda The acceptability and effectiveness of two enhanced peer lead, reproductive health promotion interventions compared to routine health care will be studied. The study participants will be individually randomized to one of three arms.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
486

participants targeted

Target at P75+ for not_applicable pregnancy

Timeline
Completed

Started Mar 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 30, 2016

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

July 20, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 27, 2016

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2017

Completed
Last Updated

May 17, 2019

Status Verified

May 1, 2019

Enrollment Period

1.7 years

First QC Date

July 20, 2016

Last Update Submit

May 15, 2019

Conditions

Keywords

adolescentreproductive health

Outcome Measures

Primary Outcomes (2)

  • Composite measure of consistent condom-use and use of an effective family planning method method

    A log-binomial regression model will be used to obtain the prevalence rate ratios.

    A comparison of this binary outcome will be conducted at one year.

  • Incidence of any Sexually Transmitted Infection

    Kaplan-Meier survival analysis will be conducted to determine differences in the probability of sexually transmitted infection between study arms.

    at one year

Study Arms (3)

Routine Care

NO INTERVENTION

Group education/counseling from Antenatal clinic midwives, routine PMTCT, HIV C\&T and family planning C\&T services on request.

Routine Care plus group support

EXPERIMENTAL

Routine Care plus enhanced group support

Behavioral: enhanced group support

Routine Care plus individual support

EXPERIMENTAL

Routine Care plus enhanced individual support

Behavioral: enhanced individual support

Interventions

Routine Care plus enhanced group support, and peer education beginning every 4 weeks post enrollment to delivery and at 6 and 10 weeks, 3, 6 and 9 months post delivery.

Routine Care plus group support

Routine Care plus individual peer education and support beginning every 4 weeks post enrollment to delivery and at 6 and 10 weeks, 3, 6 and 9 months post delivery.

Routine Care plus individual support

Eligibility Criteria

Age15 Years - 19 Years
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Pregnant at ≥28 weeks of gestation
  • Agreeing to provide written informed consent to be screened for and take part in the study
  • Agreeing to provide adequate locator information with residence within 30 km
  • Agreeing to a home visit
  • Agreeing to come for follow up visits and to receive study follow up phone calls

You may not qualify if:

  • Serious illness or social conditions that would prevent adherence to study requirements
  • High risk pregnancy or fetal death in utero (with the exception of risk defined only by maternal age)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MUJHU CARE Ltd

Kampala, Wakiso DIstrict, Uganda

Location

MeSH Terms

Conditions

Acquired Immunodeficiency SyndromeSexually Transmitted Diseases

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Florence Mirembe, MMED, PhD

    MU-JHU Care Ltd

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 20, 2016

First Posted

July 27, 2016

Study Start

March 30, 2016

Primary Completion

December 1, 2017

Study Completion

December 30, 2017

Last Updated

May 17, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share

Locations